I guess what he is saying is put OmniCAR out of your mind for...

I guess what he is saying is put OmniCAR out of your mind for the next 1-2 years potentially, until conditions are more conducive.

If PTX-100 produces more favorable data...Not a problem.

The next release of PTX-100 data could be anytime now, there has been 3 or so months since the cohort was again expanded. Provided that Professor Miles Prince was able to recruit more patients on or around the time the expanded trial was announced...Than yes, more data is possibly ready to drop.

So if Steven said yesterday that he is targeting a PTX-100 registrational trial mid 2024, than I can't see why that can't happen.

Whilst the markets conditions are frustrating, whilst it's painful to see OmniCAR moving slower than we would like...I would rather batten down the hatches as Hottod alluded to than go blowing millions every quarter on expensive cell manufacturing runs. I would personally rather see the purse strings tightened to minimize possible dilution until the share price recovers. With $20m in the bank, if we do need to raise capital anytime soon it will likely be for a PTX-100 registrational trial, which is a fantastic problem to have.

If PTX-100 gets granted a registrational trial, then it's only a matter of time before we are counting the dollars if the current data is any indication.

I'm confident that every shareholder will see their investments back above water at some stage, including those who paid 30c if PTX-100 goes to a registrational trial.